Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SOX17 antibody (AA 177-414)

There are 4+ publications for this product available. The Mouse Monoclonal anti-SOX17 antibody is suitable to detect SOX17 in samples from Human. It has been validated for WB, IHC, IF and FACS.
Catalog No. ABIN2732433
$608.40
Plus shipping costs $50.00
0.1 mL
Shipping to: United States
Delivery in 6 to 9 Business Days

Quick Overview for SOX17 antibody (AA 177-414) (ABIN2732433)

Target

See all SOX17 Antibodies
SOX17 (SRY (Sex Determining Region Y)-Box 17 (SOX17))

Reactivity

  • 54
  • 25
  • 17
  • 9
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 41
  • 10
  • 3
Mouse

Clonality

  • 43
  • 11
Monoclonal

Conjugate

  • 36
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SOX17 antibody is un-conjugated

Application

  • 44
  • 15
  • 12
  • 7
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

3B10
  • Binding Specificity

    • 19
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 177-414

    Purification

    Purified from mouse ascites fluids by affinity chromatography

    Immunogen

    Human recombinant protein fragment corresponding to amino acids 177-414 of human SOX17 (NP_071899) produced in E.coli.

    Isotype

    IgG1
  • Application Notes

    WB 1:5000, IHC 1:50, IF 1:50~100, FLOW 1:100

    Comment

    The concentration of the product may vary between diferrent lots.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5-1.0 mg/mL

    Buffer

    PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Imamura, Fujita, Tagawa, Ikura, Chen, Homma, Tamura, Mao, Taniguchi, Motoki, Nakabayashi, Ito, Yamada, Tomii, Okano, Kaye, Finkbeiner, Okazawa: "Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries." in: Scientific reports, Vol. 6, pp. 33861, (2016) (PubMed).

    Takeuchi, Nakatsuji, Suemori: "Endodermal differentiation of human pluripotent stem cells to insulin-producing cells in 3D culture." in: Scientific reports, Vol. 4, pp. 4488, (2014) (PubMed).

    Pennarossa, Maffei, Campagnol, Tarantini, Gandolfi, Brevini: "Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 22, pp. 8948-53, (2013) (PubMed).

    Zhang, Cruz, Terry, Remotti, Matushansky: "Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming." in: Oncogene, Vol. 32, Issue 18, pp. 2249-60, 2260.e1-21, (2013) (PubMed).

  • Target

    SOX17 (SRY (Sex Determining Region Y)-Box 17 (SOX17))

    Alternative Name

    SOX17

    Molecular Weight

    43.9 kDa

    Gene ID

    64321

    NCBI Accession

    NM_022454

    HGNC

    64321
You are here:
Chat with us!